Exclusion Criteria

· Subject with a history of clinically significant cardiovascular, pulmonary, hepatic, renal, hematological, gastrointestinal, endocrinal, immunologic, dermatologic, musculoskeletal, neurological, or psychiatric disease in the last 12 months

· Allergy or significant history of hypersensitivity or idiosyncratic reactions or intolerance to any food or excipients

· Subjects who showed positive result in breath alcohol and/or urine drug screening test

· Subjects determined by the study physician to have any medical condition that could jeopardize their health or prejudice the results (e.g., history of surgery of the gastrointestinal tract, which may interfere with digestion and absorption of nutrients, except for appendectomy)

· History of gastroenteritis in previous six months

· Subjects taking an unusual or special diet (for e.g., high protein diet, low sodium diet, any form of dieting, etc.)

· A known history of diabetes mellitus or the use of antihyperglycemic drugs or insulin to treat diabetes and related conditions

· First and/or second order family history of diabetes

· A major medical or surgical event requiring hospitalization within the preceding three months

· The use of steroids, protease inhibitors or antipsychotics (all of which have major effects on glucose metabolism and body fat distribution)

· Subjects with a history of alcohol, drug or substance abuse in the past 12 months

· Subjects who had used drugs known to affect glucose tolerance

· Subjects who had used enzyme-modifying drugs (like phenytoin, carbamazepine, barbiturates, griseofulvin etc.) within 30 days of Day 1 dosing

· Subjects deemed uncooperative or noncompliant

· Subjects who smoked (≥ 10 cigarettes/day or equivalent) or consumed tobacco products (≥ 4 chews of any form/day)

· Female subjects who are pregnant, lactating or likely to become pregnant or had a positive pregnancy test at screening or during check-in

· Subjects who had participated in another clinical study for at least 90 days prior to first dosing.

· Subjects who had:

o Systolic blood pressure < 90 mmHg or >140 mmHg Diastolic blood pressure < 60 mmHg or >90 mmHg

o Minor deviations (2 - 4 mmHg) at check-in were acceptable at the discretion of the investigator

o Radial pulse rate < 60/min or >100/min